Search research articles
Contact Us
Filters
Showing results (91-100 of 119) with videos related to
Page
of 12
Sort By:
The British Journal of Dermatology
|
January 20, 1999
Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial
A Grassegger, G Schuler, G Hessenberger, et al.
Advances in Clinical Chemistry
|
February 25, 2019
Clinical implications of fetuin-A
Peter Jirak, Lars Stechemesser, Elena Moré, et al.
Chest
|
September 15, 2020
Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis
Katarina Zeder, Alexander Avian, Gerhard Bachmaier, et al.
European Journal of Internal Medicine
|
November 16, 2020
Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR)
Moritz Mirna, Alexander Lauten, Peter Jirak, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 24, 2021
Teledermatological assessment of one psoriasis target lesion and patient-reported-PASI are sufficient for psoriasis monitoring
Clemens Painsi, Karin Schmid-Zalaudek, Wolfgang Weger, et al.
Chest
|
April 27, 2010
Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization
Gabor Kovacs, Robert Maier, Elisabeth Aberer, et al.
Journal of the American Academy of Dermatology
|
April 29, 1998
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial
P Mayser, U Mrowietz, P Arenberger, et al.
Journal of Dermatological Science
|
June 21, 2025
Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment
Theresa Benezeder, Natalie Bordag, Johannes Woltsche, et al.
Research Square
|
February 27, 2024
Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis
Theresa Benezeder, Natalie Bordag, Johannes Woltsche, et al.
Kidney International
|
October 27, 2018
A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health
Andreas Vychytil, Rebecca Herzog, Paul Probst, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 119) with videos related to
Sort By:
Page
of 12
The British Journal of Dermatology
|
January 20, 1999
Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial
A Grassegger, G Schuler, G Hessenberger, et al.
Advances in Clinical Chemistry
|
February 25, 2019
Clinical implications of fetuin-A
Peter Jirak, Lars Stechemesser, Elena Moré, et al.
Chest
|
September 15, 2020
Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis
Katarina Zeder, Alexander Avian, Gerhard Bachmaier, et al.
European Journal of Internal Medicine
|
November 16, 2020
Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR)
Moritz Mirna, Alexander Lauten, Peter Jirak, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 24, 2021
Teledermatological assessment of one psoriasis target lesion and patient-reported-PASI are sufficient for psoriasis monitoring
Clemens Painsi, Karin Schmid-Zalaudek, Wolfgang Weger, et al.
Chest
|
April 27, 2010
Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization
Gabor Kovacs, Robert Maier, Elisabeth Aberer, et al.
Journal of the American Academy of Dermatology
|
April 29, 1998
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial
P Mayser, U Mrowietz, P Arenberger, et al.
Journal of Dermatological Science
|
June 21, 2025
Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment
Theresa Benezeder, Natalie Bordag, Johannes Woltsche, et al.
Research Square
|
February 27, 2024
Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis
Theresa Benezeder, Natalie Bordag, Johannes Woltsche, et al.
Kidney International
|
October 27, 2018
A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health
Andreas Vychytil, Rebecca Herzog, Paul Probst, et al.
Page
of 12